Cargando…
Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or bloo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490946/ https://www.ncbi.nlm.nih.gov/pubmed/37682970 http://dx.doi.org/10.1371/journal.pone.0282814 |
_version_ | 1785103959297359872 |
---|---|
author | Lozano, Noelia Samblas, Mercedes Gomez Calabuig, Eva Giménez Martí, María José Gómez Ruiz, Maria Dolores Arce, José Miguel Sahuquillo Sequera-Arquelladas, Sergio Moreno, José Miguel Molina Trelis, M. Osuna, Antonio |
author_facet | Lozano, Noelia Samblas, Mercedes Gomez Calabuig, Eva Giménez Martí, María José Gómez Ruiz, Maria Dolores Arce, José Miguel Sahuquillo Sequera-Arquelladas, Sergio Moreno, José Miguel Molina Trelis, M. Osuna, Antonio |
author_sort | Lozano, Noelia |
collection | PubMed |
description | Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease. |
format | Online Article Text |
id | pubmed-10490946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-104909462023-09-09 Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease Lozano, Noelia Samblas, Mercedes Gomez Calabuig, Eva Giménez Martí, María José Gómez Ruiz, Maria Dolores Arce, José Miguel Sahuquillo Sequera-Arquelladas, Sergio Moreno, José Miguel Molina Trelis, M. Osuna, Antonio PLoS One Research Article Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease. Public Library of Science 2023-09-08 /pmc/articles/PMC10490946/ /pubmed/37682970 http://dx.doi.org/10.1371/journal.pone.0282814 Text en © 2023 Lozano et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lozano, Noelia Samblas, Mercedes Gomez Calabuig, Eva Giménez Martí, María José Gómez Ruiz, Maria Dolores Arce, José Miguel Sahuquillo Sequera-Arquelladas, Sergio Moreno, José Miguel Molina Trelis, M. Osuna, Antonio Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title | Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title_full | Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title_fullStr | Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title_full_unstemmed | Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title_short | Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease |
title_sort | use of sera cell free dna (cfdna) and exovesicle-dna for the molecular diagnosis of chronic chagas disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490946/ https://www.ncbi.nlm.nih.gov/pubmed/37682970 http://dx.doi.org/10.1371/journal.pone.0282814 |
work_keys_str_mv | AT lozanonoelia useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT samblasmercedesgomez useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT calabuigeva useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT gimenezmartimariajose useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT gomezruizmariadolores useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT arcejosemiguelsahuquillo useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT sequeraarquelladassergio useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT morenojosemiguelmolina useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT trelism useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease AT osunaantonio useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease |